Etiproston
Etiproston is a synthetic prostaglandin analog that has been studied for its potential use in various medical applications, particularly in the field of obstetrics and gynecology. Prostaglandins are a group of physiologically active lipid compounds that have diverse hormone-like effects in animals.
Pharmacology[edit | edit source]
Etiproston functions by mimicking the action of natural prostaglandins, which are involved in a wide range of bodily functions, including the induction of labor, regulation of inflammation, and control of blood flow. The specific mechanism of action of Etiproston involves binding to prostaglandin receptors, which leads to the modulation of intracellular signaling pathways.
Mechanism of Action[edit | edit source]
Etiproston primarily acts on the prostaglandin E2 receptor (EP receptor), which is involved in the contraction of smooth muscle tissue. This action is particularly relevant in the context of inducing labor, where Etiproston can stimulate uterine contractions.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of Etiproston includes its absorption, distribution, metabolism, and excretion. It is typically administered via routes that allow for rapid absorption, such as intravaginal or intravenous administration. The metabolism of Etiproston occurs primarily in the liver, and it is excreted through the kidneys.
Clinical Applications[edit | edit source]
Etiproston has been investigated for its use in:
- Induction of labor: Due to its ability to stimulate uterine contractions, Etiproston has been studied as an agent for inducing labor in pregnant women.
- Cervical ripening: It may also be used to prepare the cervix for labor by promoting cervical softening and dilation.
Side Effects[edit | edit source]
Common side effects associated with Etiproston include:
- Nausea
- Vomiting
- Diarrhea
- Uterine hyperstimulation
Research and Development[edit | edit source]
Research into Etiproston continues, with studies focusing on optimizing its efficacy and safety profile. Ongoing clinical trials aim to better understand its potential benefits and risks in various patient populations.
Also see[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
